Caregiver

Spring Break Water Safety Tips for Kids and Families

Retrieved on: 
Monday, March 4, 2024

Families are kicking off the spring season with spring break trips, traveling from across the country to warmer weather.

Key Points: 
  • Families are kicking off the spring season with spring break trips, traveling from across the country to warmer weather.
  • As parents tackle their packing and planning to-do lists, Big Blue Swim School reminds all caregivers to check off reviewing water and swim safety tips for the whole family.
  • Big Blue Swim School offers the following tips to make sure that families remain safe around the water this spring break:
    Remember, lifeguards are not babysitters.
  • Even with this important safety system in place at pools or beaches, adult supervision around water is essential.

This International Women’s Day, Lincoln Financial Shares Research Highlighting the Financial Challenges Women Face, and Tips for Women to Address These Challenges and Help Secure Their Financial Futures

Retrieved on: 
Monday, March 4, 2024

Make life insurance a priority: The benefits of life insurance go far beyond paying funeral costs or outstanding debt.

Key Points: 
  • Make life insurance a priority: The benefits of life insurance go far beyond paying funeral costs or outstanding debt.
  • Hospital Indemnity insurance coverage that includes maternity-related and innovative NICU enhancement benefits designed specifically for expectant mothers.
  • A broad annuities portfolio that offers investors various levels of asset protection, growth potential and protected income for life.
  • Long-term care planning products and resources that can help women prepare for tough financial decisions they and their loved ones may need to make.

Glycomine Announces Encouraging Efficacy Data from Ongoing Phase 2 Clinical Study in PMM2-CDG

Retrieved on: 
Monday, March 4, 2024

This compares favorably to prior results reported with acetazolamide which demonstrated an average improvement of 6 points after 25 weeks in adult and pediatric patients (n=25).

Key Points: 
  • This compares favorably to prior results reported with acetazolamide which demonstrated an average improvement of 6 points after 25 weeks in adult and pediatric patients (n=25).
  • “We are very encouraged by the initial results we have seen and delighted to be part of this important study.”
    The GLM101-002 Phase 2 clinical study has enrolled 10 adult patients in the U.S. and Spain (ClinicalTrials.gov Identifier: NCT05549219).
  • Study participants have received GLM101 at either 10 mg/kg (n=3), 20 mg/kg (n=3), or 30 mg/kg (n=4) for up to 24 weeks.
  • Four adolescent patients have initiated treatment, and the study is planned to be extended into younger PMM2-CDG patients in the coming months.

Global Healthy Living Foundation Announces irAE Consortium to Address Immune-Related Adverse Events in Cancer Immunotherapy Patients

Retrieved on: 
Monday, March 4, 2024

The nonprofit Global Healthy Living Foundation (GHLF) announced its collaboration as a co-founding member of the irAE Consortium, a newly formed collaborative effort uniting clinicians, researchers, and patients to tackle a critical issue facing cancer patients undergoing immunotherapy treatment: adverse reactions.

Key Points: 
  • The nonprofit Global Healthy Living Foundation (GHLF) announced its collaboration as a co-founding member of the irAE Consortium, a newly formed collaborative effort uniting clinicians, researchers, and patients to tackle a critical issue facing cancer patients undergoing immunotherapy treatment: adverse reactions.
  • The inaugural meeting of the Immune-Related Adverse Events (irAE) Consortium is scheduled for March 7-8, 2024, at the Cleveland Clinic in Ohio.
  • This initiative aims to address the unmet needs of cancer patients who experience adverse reactions to immunotherapy, a novel treatment approach.
  • Immunotherapy has revolutionized cancer treatment, offering new hope to patients by harnessing the body’s immune system to fight cancer.

Strong Tower Consulting Named One of the Best Places to Work in Consulting

Retrieved on: 
Friday, March 1, 2024

Strong Tower Consulting , a Bellevue, Washington-based management-consulting firm, was recently named as one of the Best Places to Work in Consulting by Best Companies Group.

Key Points: 
  • Strong Tower Consulting , a Bellevue, Washington-based management-consulting firm, was recently named as one of the Best Places to Work in Consulting by Best Companies Group.
  • This survey and awards program was designed to identify, recognize, and honor the best places of employment in the consulting industry.
  • Through a survey of its employees, Strong Tower was recognized for its unique “Inclusion Consulting” approach to the industry.
  • “Based on decades of experience across the consulting industry, we set out to create something that would help clients achieve great results by bringing more diverse ideas to the table,” said Strong Tower Partner Lorna Croswell.

The Food Network New York City Wine & Food Festival Announces Move to Brooklyn with Sprawling 450,000 Square Foot Culinary Campus

Retrieved on: 
Thursday, February 29, 2024

The Food Network New York City Wine & Food Festival (NYCWFF) today shares its 2024 return, debuting a move to a new 450,000 square foot culinary campus at Brooklyn Army Terminal in Sunset Park.

Key Points: 
  • The Food Network New York City Wine & Food Festival (NYCWFF) today shares its 2024 return, debuting a move to a new 450,000 square foot culinary campus at Brooklyn Army Terminal in Sunset Park.
  • “We’re incredibly excited to expand our footprint to Brooklyn and offer our most attended events at one culinary campus.
  • The Food Network New York City Wine & Food Festival is hosted by God’s Love We Deliver with 100% of the Festival’s net proceeds supporting New Yorkers facing severe illness.
  • In November 2022, BizBash named the Festival the #1 Food & Restaurant Industry event in New York for the 10th year in a row.

BioTek reMEDys Calls for Heightened Awareness of Safe Medication Use Around Rare Disease Day

Retrieved on: 
Thursday, February 29, 2024

In recognition of today being Rare Disease Day , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions.

Key Points: 
  • In recognition of today being Rare Disease Day , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions.
  • Rare Disease Day raises awareness for the 300 million people living with rare disease around the world and their families and caregivers.
  • To learn more about Rare Disease Day and rare conditions in general, visit rarediseaseday.org .
  • BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.

JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community

Retrieved on: 
Thursday, February 29, 2024

RDD activities aim to raise awareness of rare diseases and to improve the quality of life of individuals with rare and intractable diseases through better diagnoses and treatments.

Key Points: 
  • RDD activities aim to raise awareness of rare diseases and to improve the quality of life of individuals with rare and intractable diseases through better diagnoses and treatments.
  • JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) endorses the important mission of RDD and will advocate for RDD 2024 in Japan.
  • There are more than 6,000 rare diseases with an estimated 300 million individuals worldwide living with a rare disease.
  • Highlights of external awareness raising-activities for RDD:
    For JCR, RDD does not stop on the last day of February; it reminds us of our purpose every day to help raise awareness and generate change for the rare disease community worldwide.

Ketamine Wellness Clinic of Orange County Announces Acquisition of Mind Space Ketamine Infusion Clinic

Retrieved on: 
Wednesday, February 28, 2024

Ketamine Wellness Clinic of Orange County, a leader in ketamine infusion therapy for mental health and wellness, has acquired Mind Space Ketamine Infusion Clinic ("Mind Space").

Key Points: 
  • Ketamine Wellness Clinic of Orange County, a leader in ketamine infusion therapy for mental health and wellness, has acquired Mind Space Ketamine Infusion Clinic ("Mind Space").
  • The pioneering services of Mind Space will be integrated into the operations of Ketamine Wellness Clinic of Orange County, consolidating resources to enhance and expand patient care in Laguna Beach and greater Orange County.
  • Both Ketamine Wellness Clinic of Orange County and Mind Space have been revered for their innovative approaches to treating persistent mood disorders with ketamine infusion therapy.
  • "We are thrilled to welcome the Mind Space patients and their families to our clinic," said Michael Bronson, M.D., President and CEO of Ketamine Wellness Clinic of Orange County.

Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 27, 2024

Royalties for the fourth quarter of 2023 were $22.5 million, compared with $22.0 million for the same period in 2022.

Key Points: 
  • Royalties for the fourth quarter of 2023 were $22.5 million, compared with $22.0 million for the same period in 2022.
  • Costs of Captisol sales were $1.6 million for the fourth quarter of 2023, compared with $21.6 million for the same period in 2022, with the decrease due to lower total Captisol sales during the fourth quarter of 2023 and $9.8 million in accelerated depreciation on Captisol manufacturing equipment during the fourth quarter of 2022.
  • Amortization of intangibles was $8.3 million for the fourth quarter of 2023, compared with $8.5 million for the same period in 2022.
  • Travere also announced fourth quarter 2023 results reporting that it received 459 new patient start forms for FILSPARI in the fourth quarter of 2023 and net product sales of $14.9 million for the fourth quarter.